Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.
Kickingerede P, Brugnara G, Hansen MB, et al. Radiology. 2020;200978
Our unique biomarkers were used in a study to evaluate the effectiveness of the bevacizumab treatment.
Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.
Fill-out the form below, and a representative will contact you.
Perfusion Summit 2026
Date: 26 March 2026, Thursday Time: 10:15 - 17:40 (CET) Venue: Concorde Hall, Hilton Paris Hotel, CDG
Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)
Request a demo
Let us give you a tour around our solution.
Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.